Advances in Prognostic Assessment of Idiopathic Pulmonary Fibrosis: From Clinical-Physiological Parameters and Molecular Biomarkers to Multimodal Models.
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease with an extremely poor prognosis, and the rate of disease progression varies significantly among patients. Therefore, accurate prognostic assessment is crucial for clinical management. Traditional pulmonary function parameters, such as t...